Lung cancer is the third most common cancer in the UK, with around 47,800 new lung cancer cases diagnosed in the UK every year. Lung cancer has one of the lowest survival outcomes of all cancers because over two-thirds of patients are diagnosed at a late stage when curative treatment is not possible. When diagnosed at its earliest stage, 57% of people with lung cancer will survive their disease for five years or more, compared with only 3% when the cancer is diagnosed at the latest stage.
Workplace exposures are linked to 13% of lung cancer cases in the UK, a large proportion of these due to asbestos resulting in a cancer of the lining of the lungs called mesothelioma. Our researchers are combining both basic molecular biology and clinical research to advance our understanding and treatment of lung cancer.